SeqLL Inc. Stock

SeqLL Inc. is an early commercial-stage life sciences instrumentation and research services company. It is engaged in the development of scientific assets and novel intellectual property across multiple omics fields. It designs, develops, and commercializes products and services based on its genetic analysis technologies. It leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid and ribonucleic acid sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform analyse billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with microfluidics and thermal control system to perform sequencing-by-synthesis.